 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
THE PHARMACIST'S ROLE IN
CONTINUITY OF CARE IN TYPE 2 DIABETES: AN EVALUATION OF A MODEL
Ines Krass, Susan J Taylor, Adrian D McInman, and Carol L
Armour
To request full article click here.
BACKGROUND: Evidence suggests that many patients with type 2 diabetes are not achieving current evidence-based therapeutic targets.
OBJECTIVE: To compare the impact of a clinic-only versus continuity-of-care model on clinical and humanistic outcomes of patients with type 2 diabetes.
METHODS: One hundred eighteen patients were recruited from 2 diabetes clinics and assigned to a clinic-only or continuity-of-care group. The clinic-only patients were assessed by the clinic pharmacist at the initial visit and attended their usual pharmacy until the follow-up clinic visit 6 months later. The continuity-of-care patients were referred to one of 20 participating pharmacies for ongoing care over 6 months. The evaluation used a repeated measures design and compared the clinic-only with the continuity-of-care groups.
RESULTS: Within the continuity-of-care group, there was a significant reduction in mean blood glucose over the 6 months (p = 0.04). Compared with the clinic-only group, the continuity-of-care model demonstrated a trend toward a greater improvement in glycemic control. The net benefit of the intervention was an additional 0.27% (95% CI –0.63% to 0.009%) reduction in hemoglobin A1c (p = 0.15). Improvements in negative attitude and understanding of diabetes were seen in both groups; however, improvements in positive attitude to diabetes were seen only in the continuity-of-care group.
CONCLUSIONS: The continuity-of-care model had a significant impact on clinical and humanistic outcomes. Community pharmacists may enhance the care of patients with type 2 diabetes.
J Pharm Technol 2005;22:3-8.
To request full article click here.
|
|
|
||
|
